BioSphings Aktiengesellschaft

BioSphings, a biopharmaceutical company based in Frankfurt, Germany, focuses on the development of novel therapeutic approaches for the treatment of cancer, autoimmune diseases and viral infections.

The privately held company owns a portfolio of protected drug candidates which target pathways of the lipid metabolism.